000 | 01173 a2200349 4500 | ||
---|---|---|---|
005 | 20250512073210.0 | ||
264 | 0 | _c19870401 | |
008 | 198704s 0 0 fre d | ||
022 | _a0378-7966 | ||
024 | 7 |
_a10.1007/BF03189843 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBressolle, F | |
245 | 0 | 0 |
_a[Relative bioavailability in man of 2 pharmaceutical forms of canrenone]. _h[electronic resource] |
260 |
_bEuropean journal of drug metabolism and pharmacokinetics _c |
||
300 |
_a165-70 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aBiological Availability |
650 | 0 | 4 |
_aCanrenone _xblood |
650 | 0 | 4 | _aChemistry, Pharmaceutical |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHydrogen-Ion Concentration |
650 | 0 | 4 | _aIntestinal Absorption |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPregnadienes _xblood |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aBres, J | |
700 | 1 | _aFaure, A | |
700 | 1 | _aPistre, M C | |
773 | 0 |
_tEuropean journal of drug metabolism and pharmacokinetics _gvol. 11 _gno. 3 _gp. 165-70 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF03189843 _zAvailable from publisher's website |
999 |
_c3822564 _d3822564 |